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signalling is not central for controlling viral replication. The 
ability to restrict viral replication makes AMs ideal sensors of 
RSV infection and important initiators of immune responses 
in the lung.  © 2016 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 Lung infections must be carefully managed by the host 
in order to prevent detrimental effects to gas exchange 
and lung tissue integrity. A pivotal balance must be main-
tained where the pathogen is eradicated rapidly while in-
flammation remains tightly controlled. Alveolar macro-
phages (AMs) reside in the alveoli at the airway epitheli-
um and air interface, and account for over 95% of the 
leukocytes in the airways. These macrophages are a 
unique subset of mononuclear phagocytes in both pheno-
type and function  [1, 2] . They originate from fetal mono-
cytes  [3] and are believed to play a central role in main-
taining tissue homeostasis and removing cellular debris 
 [1, 2] . AMs are also crucial for the initiation of immune 
responses against invading respiratory viruses  [4–9] . 
 Respiratory syncytial virus (RSV) can cause severe 
lower respiratory tract infections especially in infants, the 
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 Abstract 
 Respiratory syncytial virus (RSV) is a common cause of lower 
respiratory tract infections. Immunity to RSV is initiated upon 
detection of the virus by pattern recognition receptors, such 
as RIG-I-like receptors. RIG-I-like receptors signal via MAVS to 
induce the synthesis of proinflammatory mediators, includ-
ing type I interferons (IFNs), which trigger and shape antiviral 
responses and protect cells from infection. Alveolar macro-
phages (AMs) are amongst the first cells to encounter invad-
ing viruses and the ones producing type I IFNs. However, it 
is unclear whether IFNs act to prevent AMs from serving as 
vehicles for viral replication. In this study, primary AMs from 
MAVS ( Mavs –/– )- or type I IFN receptor ( Ifnar1 –/– )-deficient 
mice were exposed to RSV ex vivo. Wild-type (wt) AMs but 
not  Mavs –/– and  Ifnar1 –/– AMs produced inflammatory me-
diators in response to RSV. Furthermore,  Mavs –/– and  Ifnar1 –/– 
AMs accumulated more RSV proteins than wt AMs, but the 
infection was abortive. Thus, RIG-I-like receptor-MAVS and 
IFNAR signalling are important for the induction of proin-
flammatory mediators from AMs upon RSV infection, but this 
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immunocompromised, and the elderly  [10] . Approxi-
mately 2–3% of RSV-infected children develop severe 
bronchiolitis/viral pneumonia and require hospitalisa-
tion  [10] , and many of these children are prone to recur-
rent wheeze and asthma-like symptoms in their adoles-
cence  [11] . Several studies suggest that the innate im-
mune response is indispensable for the lung to maintain 
its function while clearing RSV  [10] . RSV is recognized 
by pattern recognition receptors, which induce the pro-
duction of type I interferons (IFNs) and other cytokines 
that enhance the antiviral responses  [12] . 
 Type I IFNs exert both cell-intrinsic effects, which lim-
it viral replication, and cell-extrinsic antiviral effects, 
such as recruitment and activation of immune cells  [12, 
13] . Work from our group showed that during RSV infec-
tion, type I IFNs have a central role in both interfering 
with viral replication and driving lung inflammation dur-
ing RSV infection  [4, 14] . AMs are the main producers of 
type I IFNs in response to RSV and this production is 
initiated via recognition of RSV by cytosolic MAVS-cou-
pled pattern recognition receptors  [4, 15] . 
 Although studies suggest that AMs are early producers 
of inflammatory mediators, there is very little evidence as 
to how this production is initiated and especially how 
type I IFNs contribute to viral control in AMs. We there-
fore studied primary murine AMs deficient in MAVS and 
IFNAR1 exposed to RSV ex vivo. Our results show that 
AMs can produce several cytokines and chemokines after 
exposure to RSV and that this production is dependent 
on type I IFNs. However, AMs are not a source of all me-
diators known to be important early after RSV infection. 
Furthermore, we found that although the viral replication 
was abortive, transcription of RSV genes in both MAVS- 
and IFNAR1-deficient AMs was increased in comparison 
to wild-type (wt) AMs. Thus, AMs efficiently control RSV 
infection and are an important source of cytokines and 
chemokines during RSV infection, highlighting their role 
as important guards of the lower airways.
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 Fig. 1. AMs produce cytokines and chemokines after RSV expo-
sure. Primary wt AMs were exposed for 20 h to medium or the 
indicated MOI of RSV or UV-RSV (MOI of 2; UV2). Secretion of 
IFN-α, IFN-β, CXCL10, TNF-α, IL-6, and CCL3 were detected in 
culture supernatant by Luminex. The data are shown as means ± 
SEM of 4–9 individual cultures pooled from 2–3 experiments. Sta-
tistical significance of differences between indicated groups was 
determined by one-way ANOVA.  *  p < 0.05;  * *  p < 0.01;  * * *  p < 
0.001. 
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 Materials and Methods 
 Mice 
 C57BL/6 mice were purchased from Charles River or Harlan, 
UK, and  Ifnar1 –/– mice on a C56BL/6 background were obtained 
from C. Reis e Sousa, The Francis Crick Institute, UK.  Ifna6 gfp 
 Mavs –/– mice (obtained from S. Akira, Japan) were screened to en-
sure the genotype was maintained and are designated as  Mavs –/– to 
denote the fact that the mice may or may not have a copy of the gfp 
insert at the  Ifna6 locus. All mice were bred and maintained in 
pathogen-free conditions, and gender and age-matched mice aged 
8–14 weeks were used for each experiment. All animal experiments 
were reviewed and approved by the Animal Welfare and Ethical Re-
view Board (AWERB) within Imperial College London and ap-
proved by the UK Home Office in accordance with the Animals 
(Scientific Procedures) Act 1986 and the ARRIVE guidelines.
 Isolation of AMs 
 Mice were sacrificed and primary AMs were collected by bron-
choalveolar lavage through flushing the lungs 3 times with 1 ml of 
PBS supplemented with 5 m M EDTA (Life Technologies). The la-
vage was repeated twice and AMs from several mice were pooled. 
The purity of the AMs was >98% as determined by flow cytometry 
[4] and on cytospin counts. Collected cells were incubated in a flat-
bottom 96-well plate (1.25 × 10 5 cells/well) in complete DMEM 
(Invitrogen) containing 10% FCS (heat-inactivated from Gibco), 
2 m M  L -glutamine (Invitrogen), and 1,000 U/ml penicillin-strep-
tomycin (Sigma-Aldrich) for 3 h. After washing, the adherent cells 
were exposed to various stimuli (see below).
 Virus Infections, Cell Lines, and Innate Stimulation 
 Plaque-purified human RSV (originally the A2 strain from 
ATCC, US) was grown in HEp2 cells  [16] . Inactivation was per-
formed by exposing the virus to UV light for 2 min (UV-RSV) in 
a CX-2000 UV cross-linker (UVP). The mouse epithelial cell line 
LA4 was grown in Ham’s F12K medium containing 10% FCS 
(heat-inactivated from Gibco), 2 m M  L -glutamine (Invitrogen), 
and 1,000 U/ml penicillin-streptomycin (Sigma-Aldrich).
 AMs or LA4 cells were stimulated with different multiplicity of 
infections (MOIs) of RSV and UV-RSV, or to TLR ligands (R848 
or LPS from InvivoGen; 1 ng/ml), and incubated for 20 h. The su-
pernatant was collected and the cells were resuspended in Trizol 
for subsequent RNA extraction.
 RNA Isolation and qPCR 
 RNA extraction from AMs or LA4 was performed using Trizol 
reagent (Invitrogen) according to manufacturer’s instructions. The 
RNA then underwent DNase treatment according to manufactur-
er’s instructions (Life Technologies). 0.5–1 μg of RNA was reverse-
transcribed using the High Capacity RNA-to-cDNA kit according 
to the manufacturer’s instructions (Applied Biosystems). qPCR was 
performed to quantify mRNA levels in AMs or LA4 cells. qPCR re-
actions for  Ifnb, Ifng, Ifnl, Tnfa, Oas1a, Rsad2, Eif2ak2,  and RSV L 
and N genes were performed using primers and probes previously 
described  [4] . For the RSV, strand-specific qPCR was performed as 
previously described  [17] . Briefly, RNA extracted from AMs or LA4 
cells was converted using High Capacity cDNA reverse transcrip-
tion Kit (Qiagen) with gene-specific primers for the positive- and 
negative-sense RSV nucleocaspid region RNA. Since the primers 
contain a tag sequence, a tag-specific primer was used in the qPCR 
 [17] . Analysis was performed using the QuantiTect Probe PCR Mas-
ter Mix (Qiagen) and the 7500 Fast Real-Time PCR System (Applied 
Biosystems). Results were normalised to levels of  Gapdh , a house-
keeping gene (Applied Biosystems). For absolute quantification, the 
exact number of copies of the gene of interest was calculated using 
a plasmid DNA standard curve for each gene. For relative quantifi-
cation, the expression of RSV positive- and negative-sense strands 
 [17] ,  Ifna6 ,  Cxcl10 ,  Il6 ,  Ccl3 ,  Il1a, Il1b, Il2, Il4, Il5, Il10, Il12p40/p70, 
Il13, Il17, Cxcl1, Ccl2, Cxcl9, Csf2,  and  Vegfa  (all from Applied Bio-
systems)  were expressed relatively to the expression of  Gapdh . First, 
the ΔCt (Ct = cycle threshold) between the target gene and  Gapdh 
for each sample was calculated. Then the expression was calculated 
as 2 –ΔCt . Analysis was performed using 7500 Fast System SDS Soft-
ware (Applied Biosystems).
 Chemokine and Cytokine Detection 
 Chemokines and cytokines were quantified by a Cytokines 
Mouse Magnetic 20-Plex Panel for Luminex (Life Technologies), 
and a ProcartaPlex mouse IFN-α/IFN-β panel (eBioscience) ac-
cording to the manufacturer’s instructions and data were acquired 
using a Bio-Plex 200 system (Bio-Rad Laboratories, UK). The con-
centration of cytokines in each sample was determined according 
to the standard curve using the Bio-Plex 6 software (Bio-Rad Lab-
oratories). The concentration of CXCL10, CCL2, and TNF-α was 
additionally measured using mouse DuoSet ELISA (R&D) accord-
ing to the manufacturer’s instructions. IL-6 was detected by ELISA 
using MP5-20F3 capture antibody and biotinylated MP5-32C11 
detection antibody (both from BD Pharmingen). Data were ac-
quired on a SpectraMax Plus plate reader (Molecular Devices) and 
analysed using SoftMax software (version 5.2).
 Table 1.  Inflammatory mediators not or partially detected using 
Luminex, ELISA, or RT-PCR after 20 h of exposure of AMs to RSV 
MOI of 2
Mediator  Assay
Lu minex ELISA Gene expression
IL-1α – +
IL-1β – – +
IL-2 – –
IL-4 – –
IL-5 – –
IL-10 – –
IL12p40/p70 – –
IL-13 – –
IL-17 – –
IL-18 –
IFN-λ –
IFN-γ – –
CXCL1 – – +
CCL2 – – +
CXCL9 – +
GM-CSF – –
VEGF – –
 Data are representative of at least two experiments.
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 Fig. 2. Cytokines and chemokine production by AMs is dependent 
on MAVS and IFNAR1 signalling. Primary AMs from wt,
 Mavs –/– , and  Ifnar1 –/– mice were exposed to medium or MOI of 2 
of UV-RSV (UV) or RSV for 20 h. IFN-α and IFN-β ( a ) were de-
tected in culture supernatant by Luminex and CXCL10, TNF-α, 
and IL-6 ( b ) were detected in culture supernatant by ELISA.  c Se-
cretion of TNF-α and IL-6 from primary AMs of the indicated 
genotypes after ex vivo exposure for 20 h to medium or 1 ng/ml of 
LPS or R848.  d OAS1a, viperin, and PKR transcripts were detected 
by RT-PCR after exposure to medium or MOI of 2 of UV-RSV 
(UV) or RSV for 20 h. The data are shown as means ± SEM of 4–6 
cultures per stimulation pooled from 3 independent experiments 
( a ), 4–15 cultures per stimulation pooled from 2–6 independent 
experiments ( b ), 4–8 cultures per stimulation pooled from 2–4 in-
dependent experiments ( c ), and as 3–4 individual RNA samples 
pooled from 3–4 independent experiments ( d ). Statistical signifi-
cance of differences between indicated groups was determined by 
unpaired Student’s t test.  *  p < 0.05;  * *  p < 0.01;  * * *  p < 0.001. 
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 Staining for Fluorescence Microscopy 
 3.75 × 10 5 primary AMs were seeded in a 24-well flat-bottom 
plate containing glass coverslips. The cells were allowed to adhere 
for 3 h before exposure to medium, RSV, or UV-RSV. After 21 h 
the cells were washed with PBS and fixed with 4% paraformalde-
hyde for 10 min at RT followed by blocking with 3% BSA in 0.2% 
Triton X/PBS for a further 10 min. The cells were stained with 
polyclonal anti-RSV (1: 200; Abcam) or monoclonal anti-RSV N 
(1: 300; Abcam) and anti-LAMP-1 (1: 300; Abcam) antibodies for 
1.5 h at RT. This was followed by staining with species-specific 
secondary antibodies conjugated to Alexa Fluor 488 or Alexa Flu-
or 568 (1: 1,000; Invitrogen) for 45 min in the dark at RT. The cov-
erslips were mounted onto glass slides with ProLong ® Gold Anti-
fade Mountant with DAPI (ThermoFisher Scientific). The Zeiss 
confocal laser-scanning microscope (LSM)-510 on a 100×/1.4 
Plan-Apochromat oil lens was used for obtaining images of the 
cells. Analysis of the images was performed on Fiji, an open-source 
imaging processing software (ImageJ).
 Western Blot Analysis 
 Lysates from 8 × 10 5 primary AMs extracted using RIPA Buffer 
(Sigma) containing cOmplete Protease Inhibitors (Mini; Roche). 
Briefly, the cells were resuspended in RIPA buffer and placed on a 
rotator at 4   °   C for 30 min before being centrifuged at 12,000  g  for 
10 min at 4  °  C. The supernatant was quantified using the Peirce TM 
BCA protein assay kit (Thermo Scientific) following the manufac-
turer’s instruction. For Western blots, 5 μg of protein was added 
in each lane in a 1: 1 dilution with Laemmli buffer containing bro-
mophenol blue (Sigma). Proteins were loaded onto a 10-lane 
4–12% Bis-Tris gel (Novex) containing the MagicMark TM XP West-
ern Protein Standard (Invitrogen) markers. Gels were run in run-
ning buffer (NugePage MES SDS) before being transferred to a 
polyvinylidene difluoride filter paper sandwich with 0.45-μm pore 
membrane (Novex) using Tris-glycine transferase (Novex). The 
membranes were blocked for 1 h and then exposed to a goat-anti-
RSV antibody (1: 2,000; Abcam) or Direct-Blot TM HRP anti-β-actin 
(1: 1,000; BioLegend) at 4   °   C overnight in blocking buffer (TBS 
containing 5% BSA and 0.01% TWEEN20). The membranes were 
then incubated with a secondary anti-goat HRP antibody (1: 5,000; 
Jackson ImmunoResearch) for 1 h before being developed using 
EZ-ECL (Biological Industries). The membrane was read using a 
Fusion FX reader (Vilber Lourmat) and analysis performed using 
the Vilber Lourmat software program.
 Statistical Analysis 
 Statistical analysis was performed using GraphPad Prism 6 
(GraphPad Software Inc.). Comparisons were performed using ei-
ther an unpaired Student’s t test or one-way ANOVA with Tukey’s 
post hoc test. For all tests, p < 0.05 was considered significant.
 Results 
 AMs Produce an Array of Cytokines and Chemokines 
after RSV Exposure 
 AMs have the ability to rapidly respond to invading 
pathogens including RSV  [4] . To investigate which in-
flammatory mediators are produced by AMs after en-
countering RSV, primary AMs were exposed to RSV ex 
vivo and quantification of secreted mediators and mRNA 
was performed by Luminex and RT-PCR, respectively. 
Initially a time course (6–96 h) was performed and 18–
20 h was determined as the optimum time point to study 
both cytokine mRNA and protein induction (data not 
shown). At 20 h after RSV exposure, primary AMs pro-
duced IFN-α, IFN-β, CXCL10, TNF-α, IL-6, and CCL3 as 
detected both by Luminex ( fig. 1 ) and mRNA (see on-
line suppl. fig. S1; for all online suppl. material, see www.
karger.com/doi/10.1159/000446824). This cytokine and 
chemokine response was not triggered by UV-RSV and 
was positively correlated with RSV dose (MOI;  fig. 1 ; on-
line suppl. fig. S1). An MOI of 2 was then chosen for sub-
sequent experiments. Interestingly, there were several in-
flammatory mediators that primary AMs exposed ex vivo 
to RSV did not produce, such as IL-1α, IL-1β, IL-2, IL-4, 
IL-5, IL-10, IL-12p40/p70, IL-13, IL-17, IL-18, IFN-λ, 
IFN-γ, CXCL1, CCL2, CXCL9, GM-CSF, and VEGF, as 
assessed by Luminex and ELISA ( table 1 ). A weak mRNA 
signal but no protein was detected for  Il1a ,  Il1b ,  Cxcl1 , 
 Ccl2 , and  Cxcl9 ( table 1 ). Thus, AMs can produce many 
but not all of the early mediators detected in vivo in re-
sponse to RSV infection  [14] , suggesting that they, to-
gether with other cell types, contribute to inflammatory 
lung responses during viral infection.
 The Cytokine and Chemokine Production from AMs 
Depends on MAVS and IFNAR Signalling 
 We used primary AMs from wt,  Ifnar1 –/– , and 
 Mavs –/– mice, and exposed them ex vivo to RSV MOI of 
2. We found that both IFNAR- and MAVS-deficient AMs 
lacked the production of IFN-α, IFN-β, CXCL10, IL-6, 
and TNF-α by AMs after RSV exposure ( fig. 2 a, b). As a 
(For figure see next page.)
 Fig. 3. Accumulation of RSV proteins in  Mavs –/– and  Ifnar1 –/– pri-
mary AMs. Primary AMs from wt,  Mavs –/– , and  Ifnar1 –/– mice 
were exposed to medium or MOI of 2 of RSV or UV-RSV for 21 h 
before being fixed, stained using polyclonal-anti-RSV antibodies 
and DAPI, and analysed by fluorescence microscopy.  a Represen-
tative brightfield images of medium-exposed AMs. Representative 
images of UV-RSV-exposed primary AMs ( b ) or RSV-exposed 
primary AMs ( c ) where location of ‘inclusion-like bodies’ are pre-
sented by white arrows. Scale bar represents 10 μm. Images char-
acterise the appearance of the majority of AMs from at least 4 in-
dependent experiments. 
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control for responsiveness, AMs were stimulated with LPS 
and R848, which are known to trigger TLR4 and TLR7, 
respectively, independently of MAVS and IFNAR. LPS 
and R848 stimulation resulted in the production of IL-6 
and TNF-α from all genotypes of AMs ( fig. 2 c). However, 
 Ifnar1 –/– AMs showed decreased production of TNF-α af-
ter LPS stimulation and  Ifnar1 –/– and  Mavs –/– AMs of IL-6 
after LPS and R848 production compared to wt AMs 
( fig. 2 c). This is possibly due to the importance of type I 
IFNs in potentiating proinflammatory responses  [14] .
 Type I IFNs are known to induce several IFN-stimu-
lated genes (ISGs) that interfere with viral replication. 
Since AMs are one of the first cells to encounter virus 
particles reaching the lower airways, we investigated the 
induction of some ISGs, i.e. viperin, OAS-1, and PKR in 
AMs after ex vivo exposure to RSV (MOI of 2;  fig. 2 d). 
These ISGs have all been implicated in restricting RSV 
replication  [18–21] and were upregulated in wt AMs but 
not in IFNAR1- or MAVS-deficient AMs, in line with 
their lack of response to or induction of type I IFNs 
( fig. 2 a, d).
 IFNAR and MAVS Deficiency Leads to Increased 
Intracellular Viral Protein Accumulation and to the 
Presence of Inclusion Bodies 
 In order to assess if the lack of a type I IFN response 
and ISG induction would alter the presence and localisa-
tion of RSV proteins within AMs, fluorescence micros-
copy was performed. Staining for RSV proteins showed 
that wt AMs displayed similar punctate staining whether 
the cells were exposed to RSV or UV-RSV ( fig. 3 ). In con-
trast, IFNAR1- and MAVS-deficient AMs showed more 
of a cytoplasmic staining with larger aggregated staining 
of viral proteins that resembled inclusion bodies (IBs; 
 fig. 3 b–c). Consistent with that notion, these large cyto-
plasmic bodies could be detected with an antibody against 
the RSV N protein, which is abundant in IBs  [22] , in
IFNAR1- and MAVS-deficient AMs, but not in wt AMs 
( fig. 4 ). To distinguish phagolysosomes from IBs, staining 
for LAMP-1 was performed and demonstrated that the 
larger aggregates of viral proteins found in IFNAR1- and 
MAVS-deficient AMs did not co-stain with LAMP-1, 
suggesting that they were indeed IBs ( fig. 4 c). Further-
more, intensity analysis of the IB areas ( fig. 4 d) and pre-
liminary z-stack analysis (data not shown) confirmed that 
IBs detected in IFNAR1- and MAVS-deficient AMs are 
not within phagolysosomes.
 To further evaluate the presence of viral proteins in 
AMs, Western blot analysis using anti-RSV antibodies on 
lysate from UV-RSV- or RSV-exposed (MOI of 2) AMs 
from wt,  Mavs –/– , and  Ifnar1 –/– mice was performed 
( fig. 5 ). This analysis revealed proteins suggestive of RSV 
G, N, P, and M2-1  [23–25] in all samples (UV-RSV and 
RSV). However, in RSV-exposed  Mavs –/– and  Ifnar1 –/– 
AMs, more N was detected ( fig. 5 ), suggesting RSV pro-
tein production. Thus, when compared to wt AMs, lack 
of signalling through IFNAR1 or MAVS in AMs allows 
viral replication to advance further and enables the virus 
to form IBs.
 RSV Replication in AMs Is Restricted Even in the 
Absence of MAVS and IFNAR Signalling 
 To assess the viral load in AMs exposed to RSV ex vivo, 
RSV L and N genes were quantified. RSV L and N genes 
were detected in AMs from all genotypes from 1 to 48 h 
after exposure. In the absence of type I IFNs, IFNAR1- 
and MAVS-deficient AMs had marginally more L gene 
copies but significantly more N gene copies compared to 
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 Fig. 4. IBs are only present in AMs deficient in MAVS and IFNAR1 
signalling. Primary AMs from wt,  Mavs –/– , and  Ifnar1 –/– mice were 
exposed to MOI of 2 of RSV for 21 h. Cells were fixed and stained 
using anti-RSV-N (green), anti-LAMP-1 (red), and DAPI (blue), 
and examined by fluorescence microscopy. Representative image 
of medium-exposed AMs ( a ) and UV-RSV-exposed AMs ( b ). 
 c RSV-exposed AMs where the location of IBs is presented by 
white arrows. Images represent the appearance of the majority of 
AMs from 3 independent experiments. The scale bars represent 10 
μm. Monochrome images were converted to composite images us-
ing the Fiji software program (ImageJ).  d Graphs indicate the pix-
el intensity of RSV-N, Lamp-1, and DAPI along the white line in-
dicated on the micrographs. 
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wt AMs after RSV exposure ( fig. 6 a; online suppl. fig. S2). 
We compared this to the mouse lung epithelial cell line 
LA4, which showed a 100- to 1,000-fold increase in L and 
N gene transcripts between 1 and 48 h after infection 
( fig. 6 a). In addition, AMs or LA4 cells exposed to UV-
inactivated RSV (AM UV and LA4 UV) showed no in-
crease in L and N gene copies ( fig. 6 a; online suppl. fig. 
S2). Viral load was also assessed by immunoplaque assay 
to quantify infectious particles produced by AMs, but no 
plaques could be detected (data not shown). Further-
more, using a RSV strand-specific qPCR assay  [17] , AMs 
showed similar levels of both RSV positive- and negative-
sense strands with a slightly higher level of positive-sense 
strand RSV in  Ifnar1 –/– AMs at 24 h after RSV exposure. 
However, LA4 cells showed a significant increase in both 
RSV strands ( fig.  6 b). Altogether, these data indicate
that viral replication is slightly elevated in MAVS- and 
IFNAR-deficient AMs compared to wt AMs, but that 
RSV replicates more efficiently in the lung epithelial cells 
(LA4) compared to AMs. 
 Discussion 
 AMs are key cells of the lower airways in both health 
and disease. They have an important role in surfactant 
catabolism and clearing up debris as well as in sensing 
invading pathogens and initiating immune responses  [1] . 
Here, we show that AMs rely on MAVS and IFNAR1 sig-
nalling to produce cytokines and chemokines, including 
type I IFNs, in response to RSV exposure. However, even 
in the absence of type I IFN production or signalling, 
AMs can control viral replication, indicating that they 
possess mechanisms independent of the canonical IFN 
pathway to restrict viral infection. 
 AMs constitute a unique subset of macrophages that 
develops from fetal liver monocytes, is exposed to air, and 
is phenotypically and functionally different from other 
tissue macrophages  [2] . Therefore, in order to study these 
cells, primary AMs must be obtained from the lung, most 
commonly via bronchoalveolar lavage. AMs are the main 
producers of type I IFNs in vivo during RSV and New-
castle disease virus infection  [4, 6] . Human, ovine, and 
murine AMs have also been suggested to produce several 
cytokines and chemokines after ex vivo exposure to RSV 
 [4, 15, 23, 26–31] . We confirmed the ability of AMs to 
produce IFN-α, IFN-β, TNF-α, IL-6, CCL3, and CXCL10 
after ex vivo exposure to RSV. Interestingly, several cyto-
kines and chemokines such as CXCL1, CCL2, and IL-1β 
are known to be present in the lungs early after RSV in-
fection  [14] , yet were not produced by AMs. This high-
lights the delicate interplay between cells within the lung 
in that multiple cell types are needed in order to induce a 
proper inflammatory response to viral infections.
 Type I IFNs are important mediators to induce an an-
tiviral state in infected and neighbouring cells, and for
UV-RSV
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62 kDa
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38 kDa
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17 kDa β-Actin
   RSV
wt Mavs–/– Ifnar1–/–
G 
N 
P 
M2-1
β-Actin
 Fig. 5. The presence of RSV nucleocapsid 
protein is increased in MAVS- and IF-
NAR1-deficient AMs. Primary wt,  Mavs –/– , 
 and  Ifnar1 –/– AMs were exposed to UV-
RSV or RSV (MOI of 2) for 21 h. Cell lysate 
was generated using RIPA buffer and then 
subjected to Western blot analysis. The 
blots were exposed to a polyclonal anti-
RSV antibody or to an anti-β-actin anti-
body. The protein standard is indicated to 
the right of the blot and the detected RSV 
proteins (G, N, L, and M proteins) are in-
dicated at the right of the blots. The blots 
are representative of at least 3 experiments. 
D
ow
nl
oa
de
d 
by
: 
Im
pe
ria
l C
ol
le
ge
, S
ch
oo
l o
f M
ed
ici
ne
, W
el
lco
m
e 
Li
br
.  
 
15
5.
19
8.
8.
19
2 
- 7
/2
7/
20
16
 1
1:
15
:3
5 
AM
 Makris/Bajorek/Culley/Goritzka/
Johansson
 
J Innate Immun
DOI: 10.1159/000446824
10
1 24 48
0
10
20
40
60
80
100
120
Hours after exposure Hours after exposure 
L 
ge
ne
 fo
ld
 in
cr
ea
se
L gene
$
1 24 48
0
5
10
15
20
400
600
800
1,000
1,200
N
 g
en
e 
fo
ld
 in
cr
ea
se
N gene
##
$$$
wt
Mavs–/–
Ifnar1–/–
LA4
AM UV
LA4 UV
##
$$
Positive-sense strand RSV 
wt Mavs–/– Ifnar1–/– LA4 wt Mavs–/–  Ifnar1–/– LA4
0.0
0.5
1.0
1.5
2.0
2.5
R
el
. e
xp
. t
o 
G
ap
dh
24 h 48 h
*
Negative-sense strand RSV
wt Mavs–/– Ifnar1–/– LA4 wt Mavs–/–  Ifnar1–/– LA4
0
2
4
6
8
R
el
. e
xp
. t
o 
G
ap
dh
 (×
10
–2
)  
 
24 h 48 h
**
**
**
**
**
*
a
b
 Fig. 6. Control of replication of RSV in AMs is independent of 
MAVS and IFNAR signalling.  a AMs from wt,  Mavs –/– , and
 Ifnar1 –/– mice and LA4 cells were exposed to medium or MOI of 
2 of UV-RSV (AM UV or LA4 UV) or RSV for 1, 24, and 48 h. RSV 
L and N gene copies were determined by RT-PCR and the data are 
shown as fold increase over the copies present at 1 h after inocula-
tion. The UV AM show pooled measurements of L and N genes 
from all genotypes of AMs.  b Positive- and negative-sense strands 
of RSV were detected using RT-PCR. The data are shown as means 
± SEM of 3–4 individual RNA samples pooled from 3 independent 
experiments ( a ) and 4–6 individual RNA samples pooled from 4 
independent experiments ( b ). Each RNA sample was extracted 
from 2–3 pooled individual cultures of AMs or LA4 cells. Statisti-
cal significance of differences between indicated groups was deter-
mined by unpaired Student’s t test. In  a ‘ * ’ represents differences 
between LA4 and wt AM, ‘$’ between wt and  Ifnar1 –/– AMs and ‘#’ 
between wt and  Mavs –/– AMs.  *  p < 0.05;  * *  p < 0.01;  * * *  p < 0.001. 
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the recruitment and activation of immune cells. Human 
AMs have been shown to be less susceptible to RSV infec-
tion than nasal and bronchial epithelial cells  [32] . We 
therefore hypothesised that the lack of production of 
( Mavs –/– ) or signalling by ( Ifnar1 –/– ) type I IFNs in AMs 
would render these cells more susceptible to RSV replica-
tion. As expected, the  Mavs –/– and  Ifnar1 –/– AMs were 
unable to induce the ISGs viperin, OAS-1, and PKR, the 
viral cycle was less restricted, and more viral genes and 
proteins were detected within the cytosol compared to wt 
AMs. Yet, despite the increased accumulation of viral 
proteins in the type I IFN-deficient AMs, RSV only un-
derwent abortive replication, which resulted in detection 
of IBs. This is in contrast to cells susceptible to RSV infec-
tion, such as in the human epithelial cell line HEp2, where 
the virus forms filaments on the plasma membrane and 
IBs are less obvious  [33, 34] . How type I IFN-deficient 
AMs still managed to control the virus and how far into 
the viral life cycle is control achieved was not elucidated 
in this study. Nevertheless, increased presence of RSV N 
was detected in  Mavs –/– and  Ifnar1 –/– AMs, which would 
suggest that initiation of viral replication occurs in these 
cells. It could therefore be speculated that there is an ar-
rest either in assembly or budding. As we have not sys-
tematically compared the ability of RSV to infect multiple 
cell types, it remains possible that the restriction in viral 
replication observed in AMs is not unique. A possible rea-
son for their ability to control viral replication might be 
due to particular characteristics of AMs, such as their 
high degree of phagocytosis. Furthermore, a growing 
number of cellular factors have been reported to be re-
quired for RSV replication, such as Rab11 pathway pro-
teins, RhoA, cofilin 1, caveolin proteins, HSP90, and mi-
tochondrial proteins. It is thus possible that lack of certain 
host factors  [35–38] do not allow productive viral replica-
tion in AMs. Alternatively, AMs might have an altered 
lipid content of their cell membrane or lipid rafts com-
pared to susceptible cells such as epithelial cells, which 
could prevent release of infectious virions  [39, 40] . The 
immunofluorescence analysis of the RSV proteins in the 
wt AMs showed a very similar punctate staining of RSV- 
or UV-RSV-exposed AMs. We were not able to confirm 
if the RSV proteins were inside or bound to the surface of 
the cell. However, in the type I IFN-deficient AMs there 
were more RSV proteins detected within the cytosol, and 
the Western blot analysis and RT-PCR also showed an 
increase in RSV N proteins and genes. Altogether, this 
raises the possibility that AMs could contribute to viral 
clearance by mopping up virus from the airways, prevent-
ing productive infection of epithelial cells.
 The ability of AMs to control RSV infection would seem 
to render them as ideal sensors of infection. Human epithe-
lial cells have been suggested to be the ideal host for RSV 
 [17] . Although RSV also replicates in the mouse lung  [17, 
41] and in mouse epithelial cells (LA4), AMs did not appear 
to support viral replication to the same degree as LA4 cells. 
Thus, AMs are important for initiation of the immune re-
sponse in the lower airways after RSV infection and they are 
able to restrict viral replication even in the absence of type 
I IFNs. This positions them as excellent sensors of infection 
on the mucosal barrier. 
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